General rightsThis document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Detailed metabolic profiling of mutant strains produced by systematic inactivation of PKS and tailoring genes, along with re--feeding of isolated metabo--lites to mutant stains, has allowed the isolation of a large number of novel metabolites, identification of the 10,11--epoxidase and the full characterisation of the mupirocin biosynthetic pathway which proceeds via major (10,11--epoxide) and minor (10,11--alkene) parallel pathways.